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One sentence condensation of paper: 32 
In two record-linked birth cohorts, the effects of family history of PPH are less than those conferred 33 
by risk factors associated with the index pregnancy. 34 
Short title: 35 
Intergenerational transmission of postpartum haemorrhage 36 
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Abstract 38 
Objective: The purpose of this study was to determine risk factors for postpartum haemorrhage 39 
(PPH) including intergenerational transmission of risk of postpartum haemorrhage. 40 
Study Design: We linked birth records of women, their daughters and granddaughters in two 41 
Scottish birth cohorts: the Walker cohort (collected from 1952 to 1966) and the Scottish Morbidity 42 
Records cohort (collected from 1975 to present).  We determined clinical risk factors for PPH. We 43 
then quantified the risk of PPH in women whose mothers/grandmothers had postpartum 44 
haemorrhage before and after adjustment for these risk factors. 45 
Results: The risk of PPH in women whose mothers/grandmothers had PPH was no greater than in 46 
those whose mothers/grandmothers did not have PPH. Our study had sufficient (80%) power to 47 
detect an odds ratio (OR) of 1.3, should such an increase in odds associated with familial history 48 
exist. In contrast, the adjusted ORs conferred by nulliparity, having a large baby, Caesarean section 49 
and genital tract trauma were 1.47, 1.84, 8.20 and 9.61 respectively. 50 
Conclusion: Women whose mothers/grandmothers had PPH do not appear to be at increased risk 51 
themselves. We confirmed an increased risk of PPH associated with nulliparity, delivering a large 52 
baby, caesarean section and genital tract trauma. We were unable to demonstrate an effect of 53 
intergenerational transmission of PPH, although our study was underpowered to detect an OR less 54 
than 1.3. Thus we confirm that any risk conferred by familial history, should it exist, is less than that 55 
conferred by factors in the index pregnancy itself. 56 
Keywords: 57 
Birth cohort, epidemiology, intergenerational transmission, postpartum haemorrhage, record 58 
linkage. 59 
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Introduction 61 
Postpartum haemorrhage (PPH) is widely defined as ≥500ml blood loss from the genital tract in the 62 
first 24 hours after childbirth. It is the leading cause of maternal death worldwide, occurring in 63 
around 7-26% of all deliveries
1
 and contributing to the deaths of an estimated 125,000 women each 64 
year.
2
  The annual incidence of PPH appears to be rising steadily, even in high resource countries.
3
 65 
Known risk factors, causes and consequences of PPH are summarised in Figure 1, however the 66 
aetiology is often unclear and PPH may occur in women with no identifiable risk factors. PPH can be 67 
associated with a failure of the uterus to contract adequately after birth (atonic PPH; 90% of cases), 68 
trauma to the genital tract (traumatic PPH; 7% of cases), or bleeding due to retention of placental 69 
tissue or failure in the coagulation system (3% of cases).
4
  70 
Previous PPH is a significant risk factor for subsequent PPH, with several studies finding women two 71 
to three times more likely to have PPH in their second pregnancy if they had PPH in their first.
5–8
 If 72 
individual women are at increased risk, it is possible that this predisposition could be heritable, but 73 
to our knowledge no studies have previously addressed this. Understanding the biological and 74 
potentially heritable basis to PPH could be useful in understanding the aetiology of this important 75 
obstetric complication and developing better predictive and preventive tools. Additionally, it would 76 
help in the counselling of pregnant women, who are often aware of their family history of pregnancy 77 
related adverse events, including PPH. 78 
We used Scottish population data in which quality and consistency has previously been confirmed, 79 
and where database linkage is possible. This allowed patient-based analysis and analysis of 80 
intergenerational transmission over three generations of women. 81 
Methods 82 
Record Linkage 83 
Since the 1970’s, people living in Scotland have been allocated a unique Community Health 84 
Identification (CHI) number, which allows record linkage across clinical databases and generations. 85 
We used the CHI number to record-link between the Walker Cohort and Scottish Morbidity Records 86 
maternity admissions data (SMR02). Data were provided and by the Health Informatics Centre (HIC) 87 
at the University of Dundee. The Information Services Division (ISD) Scotland provide SMR02 data to 88 
HIC.  All data were anonymised prior to analyses. 89 
The Walker Cohort 90 
The Walker cohort is a dataset of 48404 birth records that contains meticulously recorded details of 91 
pregnancy, labour and care before discharge for births in hospital in Dundee, Scotland between 1952 92 
and 1966. The details of the Walker cohort have been previously published and will not be repeated 93 
here,
9
 but there is information about PPH stored as a dichotomous variable for Walker births 94 
occurring between 1952-58. Information on later births was recorded on different cards that did not 95 
include details of PPH. The criteria used to define PPH is not described for the Walker cohort, but we 96 
have assumed it to be ≥500ml blood loss in the first 24 hours following delivery, as diagnosed by the 97 
doctor or midwife assessing the patient. 98 
Maternities recorded in the Walker cohort account for 75% of all births in Dundee at this time. 99 
34183 (73%) of these babies can be identified through their CHI number, and this presents the 100 
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opportunity to link this maternity or birth information with a large number of current health-101 
outcome datasets covering both primary and secondary care for Walker mothers and babies. 102 
Scottish Morbidity Records – SMR02 103 
The Scottish Morbidity Records 02 (SMR02) dataset contains detailed information on hospital 104 
maternity admissions in Scotland collected from January 1975 to present. Outcomes are coded 105 
according to the International Classification of Diseases (ICD9 and ICD10). Table 1 shows the codes 106 
used to indicate PPH as an outcome. Again, we assume these codes were assigned based on 107 
observation of blood loss ≥500ml in the first 24 hours following delivery. 108 
The Generations 109 
We identified data on three generations of women, defined as follows: 110 
• Generation 1 - Walker Mothers – Women who appear in the Walker cohort as mothers. 111 
• Generation 2 - SMR02 Mothers – Women who appear in the Walker cohort as babies, and 112 
the SMR02 cohort as mothers. 113 
• Generation 3 - SMR02 Daughters – Women who appear in the SMR02 cohort as babies, and 114 
also as mothers if they have had children themselves. 115 
Data analysis 116 
In SMR02, maternity admissions that were coded as not resulting in delivery of a child were 117 
removed. Stillbirths of a baby >500g were included.  118 
We used IBM SPSS Statistics version 19 (IBM Corp., Armonk NY), to perform a univariate analysis of 119 
the pooled (Walker and SMR02) data. We calculated unadjusted odds ratios to assess the effects of 120 
each of: PPH in a previous pregnancy, multiple pregnancy, high birth weight (using the World Health 121 
Organisation (WHO) definition of ≥4kg), low birth weight (using the WHO definition of <2.5kg), 122 
maternal age under 20-years-old (previously identified as a risk factor for PPH
10
), maternal age over 123 
40-years-old (previously identified as a risk factor for PPH
10
), parity, preterm birth (using the WHO 124 
definition of ≤37 weeks’ gestation), post-term birth (using the WHO definition of ≥42 weeks’ 125 
gestation), delivery by caesarean section, instrumental delivery and smoking status on risk of PPH in 126 
the index pregnancy. To calculate adjusted odds ratios, we built factors identified as significant in 127 
the univariate analyses into a multivariate logistic regression model using function glm() in the R 128 
package lme4
11
 (R version 2.15.1
12
). 129 
To assess intergenerational transmission of PPH, we used the CHI number to link records across 130 
generations as follows:  131 
• Generation 1 was linked to Generation 2 132 
• Generation 2 was linked to Generation 3 133 
• Generation 1 was linked to  Generation 3 134 
• Pooled mother-daughter analysis: mothers from Generations 1 and 2 were linked to 135 
daughters in Generations 2 and 3. 136 
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To analyse intergenerational trends in PPH for each of these comparisons, we first calculated 137 
unadjusted odds ratios using logistic regression model, again using glm() in R package lme4.
11
 These 138 
models assess the relationship between PPH in the younger generation (the dependent variable) and 139 
PPH in the older generation (the independent variable) without taking into account any other 140 
potential covariates. We then used function glmer() in R package lme4
11
 to build generalised linear 141 
mixed models (GLMMs) using a binomial distribution with a logit link. These models incorporated 142 
any other covariates found to be significantly associated with PPH in the univariate analyses. The 143 
models also adjust for the ‘random effects’ introduced through the appearance of the same women 144 
in different mother-daughter/grandmother-granddaughter pairs (for example a woman could be a 145 
mother in the comparison of generations 2 and 3, but a daughter in the comparison in generations 1 146 
and 2. Additionally, one woman could be a mother to more than one daughter). It is important to 147 
adjust for this non-independence, because it invalidates the assumptions of many statistical tests 148 
and can introduce bias that can mask exposure effects. Where we suspected low power, we used 149 
function fe.mdor() in the R package clinfun
13
 to calculate the smallest effect size that our analyses 150 
would have been able to detect at 80% power based on our actual sample sizes. 151 
Results 152 
Figure 2 outlines how records were linked in this study and the number of records used in the final 153 
analysis. 154 
The overall prevalence of PPH (1089/25322, 4.3%) was similar in both the Walker (176/3847, 4.6%) 155 
and SMR02 (913/21475, 4.3%) cohorts. 82.3% (751) of cases of PPH in SMR02 deliveries were caused 156 
by uterine atony. PPH was diagnosed as delayed or secondary in 8.9% (81) of SMR02 cases and 157 
associated with retained placenta (third stage) in 8.4% (77). Coagulation defect was the least 158 
common recorded cause of PPH (0.4%, 4 cases). 159 
In univariate analyses of data pooled from Walker and SMR02 (Table 2), multiple pregnancy, baby 160 
birth weight over 4kg, maternal age over 40-years, preterm gestation ≤37 weeks, caesarean delivery, 161 
nulliparity, genital trauma/episiotomy and smoking during pregnancy were significant risk factors for 162 
PPH (ORs ranging from 1.17 to 6.02). Delivery by forceps or ventouse was associated with a small but 163 
significant lower risk of PPH. There were insufficient data on PPH in a previous pregnancy to 164 
determine if this was a risk factor for PPH in a subsequent pregnancy.  165 
A logistic regression model incorporating significant risk factors from the univariate analysis allowed 166 
us to adjust for confounding and revealed that large birth weight, caesarean delivery, nulliparity and 167 
genital trauma/episiotomy were significant independent risk factors for PPH (adjusted ORs ranging 168 
from 1.47 to 9.61). After these adjustments (particularly for multiple pregnancy and Caesarean 169 
section, which are significant confounders), delivery at ≤37 weeks was associated with a significant 170 
decreased risk of PPH (OR 0.63 95% CI 0.55-0.97).  171 
Table 3 shows that there is a small increased risk of PPH in women whose mothers and/or 172 
grandmothers had PPH across generations 1-2 and 1-3, but this trend did not reach statistical 173 
significance. Comparisons of generations 2 and 3 and pooling of mother and daughter comparisons 174 
showed a reverse trend, i.e a trend to a protective effect of maternal PPH on the risk of PPH in the 175 
daughter. GLMMs were used  to adjust for non-independence between related mother-daughter 176 
pairs and most risk factors identified as significant by the multivariate analysis (delivery by caesarean 177 
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section was excluded due to incomplete data). These analyses again confirmed no statistically 178 
significant effect of maternal PPH on the risk of PPH in the daughter. These intergenerational 179 
analyses had 80% power at an alpha of 0.05 to detect the following odds ratios: 2.1 for generation 1 180 
linked to generation 2; 1.3 for generation 2 linked to generation 3; 2.1 for generation 1 linked to 181 
generation 3; and 1.3 for the pooled mother to daughter analysis. Thus we can be reasonably 182 
confident that any intergenerational effect of maternal PPH, should it exist, increases the odds of 183 
PPH in the daughter by less than 1.3. 184 
Comment 185 
To our knowledge, this is the first attempt to investigate the intergenerational transmission of PPH. 186 
Our analyses do not support a large increased risk of PPH for women whose mothers/grandmothers 187 
had PPH. We identified caesarean delivery, genital trauma or episiotomy, high birth weight and 188 
nulliparity as risk factors for PPH, thus confirming the results of previous studies.
7,10,14–16
 In particular, 189 
the odds of PPH in nulliparous women (odds ratio 1.47) was very similar to that reported by Combs 190 
et al. (odds ratio 1.45).
7
 In both the SMR02 and Walker cohorts, the prevalence of PPH (4.3% and 191 
4.6%, respectively) was lower than that reported for other populations. In a meta-analysis of 104 192 
datasets, Calvert et al.
1
 showed that PPH prevalence shows high regional variation, ranging from 193 
7.2% in Oceania to 25.7% in Africa. In Europe, they found a prevalence of 12.7%, which is similar to 194 
the 13.2% incidence reported in the NHS maternity records for England and Wales in 2011-12.
17
 195 
However, the authors also found that the prevalence depends strongly on the method of diagnosis 196 
of PPH, with a subjective measurement of blood loss resulting in a lower prevalence compared to an 197 
objective measurement. A subjective measure is likely to have been used for the SMR02 and Walker 198 
cohorts, which may explain the relatively low prevalence of PPH in these datasets. Some authors 199 
have argued that the traditional definition of PPH is of little clinical relevance and should be revised 200 
so that PPH can be measured more easily and the diagnosis considers differences between individual 201 
patients.
18,19
 For example, some authors have suggested PPH may be better defined by a fall in 202 
haematocrit or percentage of total blood.
20
 Similarly, some authors have argued that using a 203 
definition of ≥500ml blood loss overestimates the prevalence of PPH associated with any increased 204 
risk of mortality or morbidity for the patient. Pritchard et al. found that 500ml is the average blood 205 
loss for a vaginal delivery, with 7% of women losing ≥1000ml of blood after vaginal delivery.
19
 They 206 
identified the average blood loss for a caesarean delivery as ≥1000ml. Therefore it could be argued 207 
that using a definition of blood loss ≥500 ml for both vaginal and caesarean deliveries will result in 208 
an overestimation of the number of cases of PPH, especially following caesarean deliveries.
21
 In 209 
SMR02 and Walker, PPH was recorded as a dichotomous variable with no information on the volume 210 
of blood loss postpartum, therefore we were unable to assess the clinical relevance of any of the 211 
cases of PPH. However, we do not consider this to be a major limitation of our study because PPH 212 
was diagnosed subjectively by trained doctors and midwives with experience of “clinically relevant” 213 
cases.  In our study there were too few cases to perform subgroup analyses on vaginal and 214 
caesarean deliveries, although we did identify caesarean section as one of the strongest 215 
independent risk factors for PPH and adjusted for caesarean section in our multivariate analyses, 216 
where possible. In contrast to previous studies,
22–25
 we saw no significant change in the prevalence 217 
of delivery by Caesarean section over time in either cohort. Therefore it is unlikely that between-218 
generation differences in the Caesarean prevalence is masking any real trends in our data. 219 
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For SMR02 only, data were available on the cause or type of PPH through ICD codes. The data quality 220 
of SMR02 and Walker was not formally assessed for the purposes of this project, however previous 221 
studies have validated these datasets, including confirmation of a low error rate in the recording of 222 
ICD diagnostic codes in SMR02.
9,26–28
 Therefore, we believe that the ICD coding used to identify cases 223 
of PPH is robust and any error in coding is not likely to introduce substantial bias. In line with 224 
previous studies,
10,29,30
 the most frequent cause of PPH was uterine atony (82.3% of cases in SMR02), 225 
which prevents constriction of blood vessels during placental separation. Unfortunately there were 226 
insufficient data to analyse risk factors for different types of PPH individually. This is a limitation of 227 
our study, as we recognise that the different aetiologies of PPH, particularly coagulation defects, 228 
may be associated with different risk factors, including family history. We decided to include in our 229 
analyses the 4 women from SMR02 with PPH associated with coagulation defects because similar 230 
cases are likely to be included in the Walker cohort and it would have been impossible to identify 231 
and exclude these cases in this dataset.No previous reports have investigated family history of PPH 232 
as a risk factor for PPH. The historical Walker data linked to the more recent SMR02 data presented 233 
a unique opportunity to do this. SMR02 data collection began in 1975, so we were able to make the 234 
same comparison within this dataset. Special consideration was given to the appearance of the same 235 
women in more than one mother-daughter/grandmother-granddaughter pair. This is further 236 
complicated by the tendency for women to experience PPH in repeat pregnancies.
5–8
 This non-237 
independence invalidates the assumptions of many statistical tests and can lead to spurious 238 
conclusions.  One option for dealing with this “clustering” is to restrict analysis to one pregnancy per 239 
woman (for example, the first pregnancy). However, this reduces statistical power and ignores a lot 240 
of potentially important information. It also changes the definition of the study population from “all 241 
births within the dataset” to “all first births within the dataset”, so it may not be possible to 242 
generalise the results to “all births”.
31
 Another possible tactic is to include data on all pregnancies 243 
and ignore the non-independence. We used this approach to calculate our “unadjusted odds ratios” 244 
for intergenerational transmission of PPH. However, this will lead to incorrect standard errors and 245 
potentially incorrect conclusions. Therefore, we used a mixed model in our final, multivariate 246 
analysis to adjust for both covariates (fixed effects) and within-woman clustering (random effects). 247 
This protects against bias and allows us to estimate the size of the effect introduced by this 248 
clustering.
31
 249 
We showed no significant association between PPH in the mother and the odds of PPH in daughters. 250 
Our study had 80% power to detect an OR of 1.29 for maternal influence on PPH in the daughter. 251 
This is a lower OR than conferred by birthweight > 4.0kg and nulliparity (1.87 and 1.47 respectively) 252 
and very much lower than conferred by maternal Caesarean section and genital tract trauma (8.20 253 
and 9.61 respectively). Thus any effect of the pregnant woman’s maternal history of PPH is (if it 254 
exists) much less significant than those of the index pregnancy. These data contrast with the known 255 
intergenerational transmission of pre-eclampsia and of preterm delivery.
32,33
 Pregnant women 256 
whose mothers had PPH can be reassured that they are unlikely to be at any significantly increased 257 
risk, compared to those whose mothers did not have PPH. 258 
Conclusion 259 
The results have confirmed several statistically significant risk factors for PPH. They also suggest that 260 
women whose mothers/grandmothers had PPH are not at an increased risk themselves. 261 
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Tables 346 
Table 1. International Classification of Diseases (ICD) 9 and 10 codes used to identify postpartum 
haemorrhage (PPH) in SMR02 birth records. 
Cause of PPH ICD-9 code ICD-10 code 
Third stage (associated with retained, trapped or adherent placenta) 666.0 O72.0 
Atonic (after placenta delivery) 666.1 O72.1 
Delayed and secondary PPH (associated with retained portions of 
placenta) 
666.2 O72.2 
Coagulation defects 666.3 O72.3 
 347 
 348 
 349 
Table 2. Analysis of risk factors associated with postpartum haemorrhage. 
Risk factor 
(A) 
Number of 
births with 
information 
on PPH and 
risk factor 
(B) 
Number of 
births with 
PPH (% of 
column A) 
(C) 
Number of 
births with 
PPH where 
risk factor is 
present (% 
of column B) 
Unadjusted 
odds ratio* 
(95% 
confidence 
interval) 
Adjusted† 
odds ratio* 
(95% 
confidence 
interval) 
Multiple pregnancy 25322 1089 
(4.3%) 
58 (5.3%) 2.09 (1.59 to 
2.76) 
1.87 (0.77 to 
4.53) ns 
Low birth weight 
(≤2.5kg) 
24935 1059 
(4.2%) 
81 (7.6%) 1.11 (0.88 to 
1.39) ns 
n/a 
High birth weight 
(≥4kg) 
24935 1059 
(4.2%) 
199 (18.8%) 2.37 (2.02 to 
2.78) 
1.84 (1.27 to 
2.67) 
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Maternal age ≤20-
years-old 
20207 1015 
(5.0%) 
136 (13.4%) 1.34 (1.12 to 
1.62) 
1.13 (0.77 to 
1.65) ns 
Maternal age ≥40-
years-old 
20207 1015 
(5.0%) 
44 (4.3%) 2.73 (1.98 to 
3.77) 
1.32 (0.73 to 
2.38) ns 
Nulliparity 25293 1085 
(4.3%) 
541 (49.9%) 1.17 (1.03 to 
1.32) 
1.47 (1.10 to 
1.98) 
Preterm birth (≤37 
weeks' gestation) 
23741 1003 
(4.2%) 
127 (12.7%) 1.33 (1.1 to 
1.61) 
0.63 (0.41 to 
0.97) ns 
Postterm birth (≥42 
weeks' gestation) 
23741 1003 
(4.2%) 
81 (8.1%) 0.79 (0.63 to 
1.00) ns 
n/a 
Delivery by 
caesarean secXon† 
3872 471 
(12.2%) 
283 (60.1%) 6.02 (4.92 to 
7.38) 
8.20 (6.19 to 
10.86) 
Instrumental 
delivery (forceps or 
ventouse) 
3872 471 
(12.2%) 
21 (4.5%) 0.42 (0.27 to 
0.66) ns 
n/a 
Genital trauma or 
episiotomy 
18890 885 (4.7%) 25 (2.8%) 1.61 (1.07 to 
2.44) 
9.61 (2.15 to 
43.02) 
Mother smoked 
during pregnancy 
8833 573 (6.5%) 140 (24.4%) 1.40 (1.15 to 
1.71) 
0.79 (0.57 to 
1.08) ns 
ns: non significant. 350 
* ratio of the odds of a birth being affected by PPH when the risk factor is present to the odds of a 351 
birth being affected by PPH when the risk factor is absent. 352 
†adjusted for all factors identified as significant in the univariate (anadjusted) analysis. 353 
 354 
 355 
 356 
 357 
 358 
 359 
 360 
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Table 3. Analysis of intergenerational trends in postpartum haemorrhage. 
Risk factor 
(A) 
Number of 
linked births 
with 
information 
on PPH 
(B) 
Number of 
linked 
births with 
PPH in 
younger 
generation 
(% of 
column A)  
(C) 
Number of 
linked 
births with 
PPH in 
both 
generation
s (% of 
column B) 
Unadjust
ed odds 
ratio 
(95% 
confidenc
e 
interval) 
Adjusted* 
odds ratio 
(95% 
confidence 
interval) 
PPH in generation 1 
as a risk factor for 
PPH in generation 2 
2543 49 (1.9%) 3 (6.1%) 
1.32 (0.41 
to 4.32) 
1.20 
(4.83e-3 to 
296.0) 
PPH in generation 2 
as a risk factor for 
PPH in generation 3 
2464 
290 
(11.8%) 
4 (1.4%) 
0.68 (0.24 
to 1.90) 
0.58 (8.0e-
3 to 41.61) 
PPH in generation 1 
as a risk factor for 
PPH in generation 3 
519 65 (12.5%) 6 (9.2%) 
2.21 (0.85 
to 5.72) 
1.33 
(9.43e-5 to 
1.88e+4) 
PPH in mothers as a 
risk factor for PPH in 
daughters (pooled 
analysis) 
5007 339 (6.8%) 7 (2.1%) 
0.59 (0.27 
to 1.27) 
0.69 (0.06 
to 7.62) 
*calculated using a generalised linear mixed model to adjust for the non-independence between 361 
linked births and risk factors identified as significant in the multivariate analysis (excluding delivery 362 
by caesarean section because of incomplete data). 363 
 364 
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Figure legends 365 
Figure 1. Causes, risk factors and consequences of postpartum haemorrhage, as identified 366 
previously. 367 
Figure 2. Method of record linkage and number of records analysed. 368 
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Background and Objective 
Postpartum hemorrhage (PPH) is widely defined as ≥500 mL blood loss from the genital 
tract in the first 24 hours after childbirth. It is the leading cause of maternal death 
worldwide, occurring in around 7-26% of all deliveries and contributing to the death of an 
estimated 125,000 women each year. 
Understanding the biological and potentially heritable basis of PPH could be useful 
in understanding the etiology of this important obstetric complication and developing better 
predictive and preventive tools. In addition, it would help in the counseling of pregnant 
women, who are often aware of their family history of pregnancy-related adverse events, 
including PPH. 
 
Materials and Methods 
We used the CHI number to record-link between the Walker Cohort and Scottish Morbidity 
Records maternity admissions data (SMR02). The Walker cohort is a dataset of 48,404 birth 
records that contains meticulously recorded details of pregnancy, labor, and care before 
discharge for births in hospital in Dundee, Scotland, in 1952-1966. 
Maternities recorded in the Walker cohort account for 75% of all births in Dundee at 
this time. Among these babies, 34,183 (73%) can be identified through their CHI number. 
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This presents the opportunity to link this maternity or birth information with a large number 
of current health outcome datasets covering both primary and secondary care for Walker 
mothers and babies. 
The Scottish Morbidity Records 02 (SMR02) dataset contains detailed information 
on hospital maternity admissions in Scotland collected from January 1975 to the present. We 
identified data on 3 generations of women. 
 
Results 
The overall prevalence of PPH (1089/25,322, 4.3%) was similar in both the Walker 
(176/3847, 4.6%) and SMR02 (913/21,475, 4.3%) cohorts. Among cases of PPH in SMR02 
deliveries, 82.3% (751) were caused by uterine atony. PPH was diagnosed as delayed or 
secondary in 8.9% (81) of SMR02 cases and associated with retained placenta (third stage) 
in 8.4% (77). Coagulation defect was the least common recorded cause of PPH (0.4%, 4 
cases). 
In univariate analyses of data pooled from Walker and SMR02, multiple pregnancy, 
baby birthweight over 4kg, maternal age over 40 years, preterm gestation ≤37 weeks, 
cesarean delivery, nulliparity, genital trauma/episiotomy, and smoking during pregnancy 
were significant risk factors for PPH (ORs ranging from 1.17 to 6.02). Delivery by forceps 
or ventouse was associated with a small but significant lower risk of PPH. There were 
insufficient data on PPH in a previous pregnancy to determine whether this was a risk factor 
for PPH in a subsequent pregnancy.  
A logistic regression model incorporating significant risk factors from the univariate 
analysis allowed us to adjust for confounding and revealed that high birthweight, cesarean 
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delivery, nulliparity, and genital trauma/episiotomy were significant independent risk factors 
for PPH (adjusted ORs ranging from 1.47 to 9.61). After these adjustments (particularly for 
multiple pregnancy and cesarean section, which are significant confounders), delivery at ≤37 
weeks was associated with a significant decreased risk of PPH (OR 0.63; 95% CI, 0.55-
0.97). 
Women whose mothers and/or grandmothers had PPH had a small increased risk of 
PPH across generations 1-2 and 1-3, but this trend did not reach statistical significance 
(Table). We can be reasonably confident that any intergenerational effect of maternal PPH, 
should it exist, increases the odds of PPH in the daughter by less than 1.3. 
 
Comment 
To our knowledge, this is the first attempt to investigate the intergenerational transmission 
of PPH. Our analyses do not support a large increased risk of PPH for women whose 
mothers/grandmothers had PPH. We identified cesarean delivery, genital trauma or 
episiotomy, high birthweight, and nulliparity as risk factors for PPH, thus confirming the 
results of previous studies. 
Some authors have argued that the traditional definition of PPH is of little clinical 
relevance and should be revised so that PPH can be measured more easily and the diagnosis 
considers differences between individual patients. In SMR02 and Walker, PPH was recorded 
as a dichotomous variable with no information on the volume of blood loss postpartum; 
therefore, we were unable to assess the clinical relevance of any of the cases of PPH. 
However, we do not consider this to be a major limitation of our study because PPH was 
diagnosed subjectively by trained doctors and midwives with experience of “clinically 
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relevant” cases. 
In line with previous studies, the most frequent cause of PPH was uterine atony 
(82.3% of cases in SMR02), which prevents constriction of blood vessels during placental 
separation. Unfortunately, data were insufficient to analyze risk factors for different types of 
PPH individually.  
No previous reports have investigated family history of PPH as a risk factor for PPH. 
The historical Walker data linked to the more recent SMR02 data presented a unique 
opportunity to do this. Special consideration was given to the appearance of the same 
women in more than one mother-daughter/grandmother-granddaughter pair. This is further 
complicated by the tendency for women to experience PPH in repeat pregnancies. This 
nonindependence invalidates the assumptions of many statistical tests and can lead to 
spurious conclusions. 
Therefore, we used a mixed model in our final, multivariate analysis to adjust for 
both covariates (fixed effects) and within-woman clustering (random effects). This protects 
against bias and allows us to estimate the size of the effect introduced by this clustering. 
We showed no significant association between PPH in the mother and the odds of PPH in 
daughters. Our study had 80% power to detect an OR of 1.29 for maternal influence on PPH 
in the daughter. This is a lower OR than conferred by birthweight >4.0 kg and nulliparity 
(1.87 and 1.47, respectively) and very much lower than conferred by maternal cesarean 
section and genital tract trauma (8.20 and 9.61, respectively). Thus any effect of the 
pregnant woman’s maternal history of PPH is (if it exists) much less significant than those 
of the index pregnancy.  
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CLINICAL IMPLICATIONS 
•  Pregnant women whose mothers experienced postpartum hemorrhage (PPH) can be 
reassured that they are unlikely to be at any significantly increased risk compared to those 
whose mothers did not experience PPH. 
 
[Insert Table 3. Analysis of intergenerational trends in postpartum hemorrhage] 
 
 
